Comerica Bank
COGT icon

Comerica Bank’s Cogent Biosciences COGT Stock Holding History

Comerica Bank’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$37.5K Sell
1,057
-215
-17% -$6.04K ﹤0.01% 2946
2025
Q3 		$18.3K Hold
1,272
– – ﹤0.01% 3111
2025
Q2 		$9.13K Hold
1,272
– – ﹤0.01% 3236
2025
Q1 		$7.62K Sell
1,272
-788
-38% -$6.18K ﹤0.01% 3235
2024
Q4 		$16.1K Buy
2,060
+336
+19% +$3.35K ﹤0.01% 3085
2024
Q3 		$18.6K Hold
1,724
– – ﹤0.01% 3048
2024
Q2 		$14.5K Buy
1,724
+452
+36% +$3.43K ﹤0.01% 3076
2024
Q1 		$8.55K Buy
+1,272
New +$7.86K ﹤0.01% 3212

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Comerica Bank's COGT Position: Q4 2025 in Review

Comerica Bank reduced its Cogent Biosciences (COGT) stake by 17% in Q4 2025, selling an estimated $6.04K and leaving 1,057 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Comerica Bank first reported a position in COGT in Q1 2024 and has held it in 8 quarters since. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • Comerica Bank held 1,057 shares of Cogent Biosciences worth $37.5K as of Q4 2025.
  • Comerica Bank sold 215 Cogent Biosciences shares in Q4 2025, an estimated $6.04K.
  • Cogent Biosciences made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2946 holding.
  • Comerica Bank first reported a position in Cogent Biosciences in Q1 2024 and has held it in 8 quarters since.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.